BT
Beam Therapeutics Inc
🇺🇸XNAS.BEAMUnited StatesHealthcare
$23.01USDdown -0.24 (-1.03%)ClosedDelayed11:01 PM
Price$23.01-0.24 (-1.03%)
Profile
- Healthcare
- Biotechnology
- United States
Identity
- Exchange
- Nasdaq . XNAS
- Type
- Stock
- ISIN
- US07373V1052
- CUSIP
- 07373V105
Company
- Employees
- 540
- Headquarters
- Cambridge, United States
- Website
- https://beamtx.com
- CEO
- Mr. John M. Evans M.B.A.
Market
- Shares outstanding
- 103.3M
- Market cap
- $2.38B
Key dates
- Next earnings
- Nov 3, 2026
Highlights
- Market cap
- $2.39B
- EPS LTM
- -$0.83calculatedCalculated by Finzer, not reported by the data provider.
- P/E LTM
- -27.82calculatedCalculated by Finzer, not reported by the data provider.
- Div yield
- Not reported
Fundamentals (LTM)
- Revenue
- $156.04M+158.88%up year on year
- Net income
- -$85.43M+78.57%up year on year
- Gross margin
- 18.93%+103.4%up year on year
- Free cash flow
- -$372.77M-4.84%down year on year
Other listings
This company is not listed on any other exchange we cover.
These are the venues Finzer covers, not every venue that exists.
Business summary
No company summary reported yet.